Psych

Introduction As MDMA- and psilocybin-assisted therapy move closer to FDA approval, many Californians are beginning to ask an important question: How much will psychedelic therapy cost? While final pricing will depend on federal regulations, clinical requirements, and insurance policies, we can create realistic projections based on existing research protocols, ketamine therapy models, and early clinic […]

Introduction MDMA-assisted therapy has emerged as one of the most promising treatments for Post-Traumatic Stress Disorder (PTSD). With decades of research behind it and multiple Phase 3 clinical trials showing breakthrough results, MDMA-assisted therapy has attracted national attention as a potential major advance in trauma treatment. This article explains how MDMA therapy works, why it […]

Introduction Psilocybin-assisted therapy is rapidly gaining attention as clinical trials show compelling benefits for depression, anxiety, end-of-life distress, and other conditions. California, with its large healthcare ecosystem and strong public interest in emerging mental health treatments, is positioned to become one of the earliest hubs once psilocybin receives FDA approval. This guide explains the current […]

Introduction Psychedelic-assisted therapy (PAT) is one of the most exciting developments in mental health care in decades. Backed by rigorous research from leading institutions, PAT blends psychotherapy with medicines like MDMA or psilocybin to help individuals access emotional breakthroughs, process trauma, and create lasting change. Although full FDA approval is still pending for MDMA and […]